Data / Form D filings / Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc.: Form D filings
Enliven Therapeutics, Inc., a pharmaceuticals company in Boulder, CO, filed 3 Form D notices with the SEC between 2016 and 2024. The latest, on April 3, 2024, reports $90 million sold of a $90 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6200 LOOKOUT ROAD, Boulder, CO, 80301
- Phone
- (720) 647-8519
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1672619
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | New notice | $90,001,086 | $90,001,086 | 20 | Mar 21, 2024 | sec.gov | |
| Mar 29, 2019 | New notice | $62,998,708 | $44,099,096 | $18,899,612 | 11 | Mar 15, 2019 | sec.gov |
| Apr 21, 2016 | New notice | $30,999,971 | $6,000,000 | $24,999,971 | 7 | Apr 13, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Helen P. Collins | Executive Officer | |
| Andrew P. Phillips | Director | |
| Richard P. Heyman | Director | |
| Mika P. Derynck | Director | |
| Benjamin P. Hohl | Executive Officer | |
| Anish P. Patel | Executive Officer | |
| Joseph P. Lyssikatos | Executive Officer, Director | |
| Jake P. Bauer | Director | |
| Rahul P. Ballal | Director | |
| Rishi P. Gupta | Director | |
| Samuel Kintz | Executive Officer, Director |
Every Form D from the week of Apr 1, 2024 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Enliven Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.